Open company graph database — free web & API
Login

Kaken Seiyaku Co., Ltd.

化研生薬株式会社
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
50
Related companies
5
§01

Basic information

BASIC
Head office
1-11-12 Oyama-cho, Nakano-ku, Tokyo 165-0034, Japan
Chief executive
Tomoki Ikemoto
Capital
51,630,000
Employees (non-consolidated)
50 people
Employees (consolidated)
50 people
Start date
1942-07-31
End date
§02

Websites

1 DOMAINS
§03

Business

2
Medical pharmaceutical sales businessPharmaceutical manufacturing business
§04

Related companies

5 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Sawai Pharmaceutical Co., Ltd.
Group Parent
Sawai Group Holdings Co., Ltd.
Group Parent
Trust PharmaTech Co., Ltd.
Group
Medisa New Drug Inc.
Group
FrontAct Corporation
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

22 EVENTS

From 1905, for 19 years, detailed studies were conducted on plants from Taiwan. Tamashikizudara Fuji was one of them, and it was published as the plant "Stephania cepharantha HAYATA" in the "Taiwan Plant Atlas (Illustrated)".Sources

Dr. Heizaburo Kondo, who was researching alkaloids of the Tsuudara-fuji family, discovered a new alkaloid from the roots of Tamashikizudara Fuji in 1928 and named it "Cepharanthine."Sources

Cepharanthine was discovered from the Taiwan-native plant family Araliaceae "Tamashikizudara Fuji."Sources

In 1938, the "Chemotherapy Research Association" was established to advance research on Cepharanthine.Sources

Foundation of the Chemotherapy Research SocietySources

In 1942, due to increased demand for Cepharanthine as research progressed, the production, cultivation, and sales divisions that had been carried out by the Chemotherapy Research Association were separated into a corporate entity, forming Kaken Seiyaku Co., Ltd.Sources

With a capital of 190,000 yen, Kaken Seiyaku Co., Ltd. was established in Kudan, Tokyo.Sources

After clinical trials were conducted in many hospitals and convalescent homes, "Cepharanthine®" received approval for pharmaceutical manufacturing as an active ingredient in July 1942.Sources

Opening of Osaka BranchSources

Capital increased to 2,000,000 yen; Mitaka factory opened.Sources

The end of the war resulted in the loss of all business, facilities, and assets in Taiwan.Sources

Cultivation trials began in Yago Town, Niihari District, Ibaraki Prefecture (now Ishioka City).Sources

Starting with the Izu region of Shizuoka Prefecture, which has a climate relatively similar to Taiwan, domestic cultivation efforts began.Sources

Records suggest that cultivation was carried out in the fields of Yago.Sources

New headquarters building constructed for the Mitaka factory, main office, and Tokyo sales office.Sources

Kaken Seiyaku established the Yago factory, handling everything from raw material cultivation and management to the manufacturing of the active ingredient.Sources

Opening of Yagō FactorySources

Capital increased to 8,410,000 yen.Sources

Capital increased to 20,900,000 yen.Sources

Capital increased to 51,630,000 yen.Sources

Became a subsidiary of the Sawai Group (Sawai Pharmaceutical Co., Ltd.).Sources

Becomes a 100% subsidiary of Sawai Group Holdings, Inc.Sources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information5120001160859
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
化研生薬株式会社
Trade name (kana)
カケンショウヤク
Name in English
Corporation type
301
Address
〒535-0005 大阪府大阪市旭区赤川2丁目7番4号沢井ビル4階
Postal code
5350005
Prefecture code
27
City code
117
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2020-06-30
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
4207169
METI gBizINFO5120001160859
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
5120001160859
Trade name
化研生薬株式会社
Trade name (kana)
カケンショウヤク
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
大阪府大阪市旭区赤川2丁目7番4号沢井ビル4階
Postal code
5350005
Prefecture
大阪府
Prefecture code
27
City or district
大阪市旭区
City code
117
Street address
赤川2丁目7番4号沢井ビル4階
Organisation type
301
Processing type
01
Correction type
1
Status
Representative
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2020-06-30
Key information
5120001160859
§09

Sources & updates

SOURCES
↑